Literature DB >> 20304423

Fatal familial lung disease caused by ABCA3 deficiency without identified ABCA3 mutations.

W Adam Gower1, Susan E Wert, Jennifer S Ginsberg, Agneta Golan, Jeffrey A Whitsett, Lawrence M Nogee.   

Abstract

OBJECTIVE: To test the hypothesis that some functionally significant variants in the gene encoding member A3 of the ATP Binding Cassette family (ABCA3) are not detected using exon-based sequencing approaches. STUDY
DESIGN: The first of 2 female siblings who died from neonatal respiratory failure was examined for mutations with sequence analysis of all ABCA3 exons and known regulatory elements within the 5' untranslated region. Lung tissue from both siblings was immunostained for ABCA3 and examined with electron microscopy. Segregation of ABCA3 alleles was determined with analysis of polymorphisms in the parents and all children.
RESULTS: No mutations were identified with ABCA3 sequence analysis in the first affected infant. Affected siblings were concordant for their ABCA3 alleles, but discordant from those of their unaffected siblings. ABCA3 protein was not detectable with immunostaining in lung tissue samples from both affected infants. Electron microscopy demonstrated small, dense lamellar bodies, characteristically seen with ABCA3 mutations.
CONCLUSIONS: The segregation of ABCA3 alleles, absence of ABCA3 immunostaining, lung pathology, and ultrastructural findings support genetic ABCA3 deficiency as the cause of lung disease in these 2 infants, despite the lack of an identified genetic variant. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304423     DOI: 10.1016/j.jpeds.2010.01.010

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Large ABCA3 and SFTPC deletions resulting in lung disease.

Authors:  Lindsay B Henderson; Kristin Melton; Susan Wert; Jonathan Couriel; Andrew Bush; Michael Ashworth; Lawrence M Nogee
Journal:  Ann Am Thorac Soc       Date:  2013-12

Review 2.  Surfactant dysfunction.

Authors:  W Adam Gower; Lawrence M Nogee
Journal:  Paediatr Respir Rev       Date:  2011-03-05       Impact factor: 2.726

Review 3.  Interstitial lung disease in children.

Authors:  Christin S Kuo; Lisa R Young
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

Review 4.  Surfactant protein disorders in childhood interstitial lung disease.

Authors:  Jagdev Singh; Adam Jaffe; André Schultz; Hiran Selvadurai
Journal:  Eur J Pediatr       Date:  2021-04-11       Impact factor: 3.183

Review 5.  Pulmonary alveolar proteinosis: from classification to therapy.

Authors:  Elena Salvaterra; Ilaria Campo
Journal:  Breathe (Sheff)       Date:  2020-06

6.  Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations.

Authors:  Hiroshi Kitazawa; Kunihiko Moriya; Hidetaka Niizuma; Kengo Kawano; Yuka Saito-Nanjo; Toru Uchiyama; Takeshi Rikiishi; Yoji Sasahara; Osamu Sakamoto; Yasuhiro Setoguchi; Shigeo Kure
Journal:  Eur J Pediatr       Date:  2013-02-27       Impact factor: 3.183

7.  An intronic ABCA3 mutation that is responsible for respiratory disease.

Authors:  Amit Agrawal; Aaron Hamvas; F Sessions Cole; Jennifer A Wambach; Daniel Wegner; Carl Coghill; Keith Harrison; Lawrence M Nogee
Journal:  Pediatr Res       Date:  2012-02-15       Impact factor: 3.756

8.  Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.

Authors:  Li Peng; Xiu Wu Bian; Di Kang Li; Chuan Xu; Guang Ming Wang; Qing You Xia; Qing Xiong
Journal:  Sci Rep       Date:  2015-08-21       Impact factor: 4.379

9.  Heterozygosity for E292V in ABCA3, lung function and COPD in 64,000 individuals.

Authors:  Marie Bækvad-Hansen; Børge G Nordestgaard; Morten Dahl
Journal:  Respir Res       Date:  2012-08-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.